On Monday, BrightSpring Hlth Svcs reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 95, up from 89 the day before.
IBD's proprietary rating measures share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
History reveals that the market's biggest winners typically have an RS Rating north of 80 as they launch their biggest runs.
How To Use Stock Charts To Stay Profitable And Protected
BrightSpring Hlth Svcs has moved more than 5% past a 12.21 entry in a first-stage cup without handle, meaning it's now out of a proper buy zone. Look for the stock to offer a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week line.
While the company's bottom line growth decreased in the company's most recently reported quarter from 233% to 0%, revenue rose 29%, up from 26% in the prior report.
BrightSpring Hlth Svcs earns the No. 2 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
